Pharma & Biotech

FDA Grants Orphan Drug Status to Sanofi’s Rilzabrutinib: A New Hope for wAIHA, IgG4-RD, and Beyond

(IN BRIEF) Rilzabrutinib, an investigational oral BTK inhibitor, has received orphan drug designation from the FDA for treating warm autoimmune…

6 months ago

Basel Unveils Cutting-Edge R&D Hub Fueling Next-Gen Cancer Therapy Innovations

(IN BRIEF) Boehringer Ingelheim, via its subsidiary NBE Therapeutics, has launched a cutting-edge ADC research and development facility in Basel…

6 months ago

IO Biotech Secures €57.5M EIB Venture Debt to Advance Breakthrough Cancer Vaccine

(IN BRIEF) IO Biotech, a Danish med-tech company, has obtained €57.5 million in venture debt financing from the European Investment…

7 months ago

Sanofi Accelerates Chlamydia Prevention with Fast Tracked mRNA Vaccine

(IN BRIEF) Sanofi’s mRNA vaccine candidate for chlamydia has been granted fast track designation by the US FDA, reflecting its…

7 months ago

Symrise Unveils Nature-Driven Synergistic Complex for Soothing Sensitive Skin

(IN BRIEF) SymRelief® green is the latest innovation from Symrise, formulated to revolutionize sensitive skincare with a patented synergistic complex…

7 months ago

EQT Foundation Launches Global Grants to Drive Deeptech Innovation in Women’s Health

(IN BRIEF) The EQT Foundation has opened a global call for proposals under its Breakthrough Science grants program, offering grants…

7 months ago

Revolutionizing Cardiology Data: DT4H Launches a Secure, AI-Driven Toolbox for Patient Care

(IN BRIEF) The DataTools4Heart (DT4H) project, funded under the European Union’s Horizon Europe Framework, has successfully concluded its initial development…

7 months ago

New Insights into ATRX Mutations Offer Hope for Tailored Neuroblastoma Treatments

(IN BRIEF) Scientists at The Institute of Cancer Research in London have made significant strides in understanding why some cases…

7 months ago